Stock Price
49.82
Daily Change
0.06 0.12%
Monthly
1.88%
Yearly
-0.66%
Q2 Forecast
48.22

Recordati reported EUR199.91M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Almirall EUR 191.5M 2.29M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Orion EUR 163.7M 22.9M Mar/2026
Sanofi EUR 3.67B 621M Mar/2026